Skip to content

Integra LifeSciences IART Cash Flow Statement

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
-$4.62M+81.7%-$1.7M-$5.4M+49.5%-$484.07M-3,803%-$25.29M-671%
$38.43M+3.3%$38.43M+2.2%$38.52M+7.1%$37.69M+2.5%$37.19M+21.7%
$5.17M+176%$5.84M-18.4%$5.58M+27.3%$5.3M-26.9%$1.87M-66.6%
$9.8M+187%$11.82M-76.7%$40.91M+81.9%$8.92M-77.9%-$11.26M-171%
$14.85M-48.7%$17.21M-41.8%$15.16M-48.9%$20.15M-32.2%$28.92M+87.0%
-$14.85M+58.7%-$34.91M-722%-$15.59M-49.9%-$21.65M+93.3%-$35.92M+33.4%
$8.3M-76.5%$24.34M$35.38M-90.1%
$1.76M+124%-$21.19M+94.4%-$7.27M-102%
-$5.05M+87.4%-$5.4M-126%-$11.23M-205%-$40.18M-13,907%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Integra LifeSciences generate?
Integra LifeSciences (IART) generated $71.4M in operating cash flow over the trailing twelve months.
What is Integra LifeSciences's free cash flow?
After $67.4M of capital expenditures, Integra LifeSciences's free cash flow was -$61.8M over the trailing twelve months, down 193.2% year over year.
Where does Integra LifeSciences's cash flow data come from?
Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.